首页> 外文期刊>The Journal of Allergy and Clinical Immunology >Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma.
【24h】

Bronchodilation and bronchoconstriction: predictors of future lung function in childhood asthma.

机译:支气管扩张和支气管收缩:儿童哮喘未来肺功能的预测因子。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Persistently low levels of lung function are associated with subsequent symptoms in patients with asthma as children. OBJECTIVES: We hypothesized that objective measures of baseline pulmonary function would be independently associated with future lung function in the Childhood Asthma Management Program and that these associations might vary with treatment. METHODS: We evaluated the association of FEV1, airway responsiveness, and bronchodilator response at randomization as predictors of longitudinal growth in FEV1 at the 48-month follow-up visit in the 1041 Childhood Asthma Management Program participants. RESULTS: Baseline levels of airway responsiveness and bronchodilator response were significantly associated with baseline level of lung function. In multivariate models, higher bronchodilator response (beta = 0.22; P < .0001), log PC20 (beta = 1.82; P < .0001), and FEV1 (beta = 0.58; P < .0001) at randomization were each associated with higher levels of prebronchodilator FEV1, as a percentof predicted, after 4 years. Similar associations were noted for prebronchodilator forced vital capacity and FEV1/forced vital capacity ratio. Baseline bronchodilator response was a particularly powerful predictor of lung function improvements while on inhaled corticosteroids, whereas airway responsiveness was a better predictor in subjects not randomized to any controller medications. CONCLUSION: We conclude that baseline bronchodilator response, airway responsiveness, and level of FEV1 are independent predictors of subsequent level of FEV1 in childhood asthma and may have treatment-specific prognostic significance for persistence of symptoms into early adulthood. CLINICAL IMPLICATIONS: In asthma, bronchodilator and bronchoconstrictor responses are independent predictors of future lung function and should not be used interchangeably; bronchodilator response may indicate good response to inhaled corticosteroids.
机译:背景:肺功能持续低下与儿童哮喘患者的后续症状有关。目的:我们假设在儿童哮喘管理计划中,基线肺功能的客观测量将与未来肺功能独立相关,并且这些相关性可能随治疗而变化。方法:在1041例儿童哮喘管理计划参与者的48个月随访中,我们评估了FEV1,气道反应性和支气管扩张剂反应的相关性,作为FEV1纵向增长的预测指标。结果:气道反应性和支气管扩张剂反应的基线水平与肺功能的基线水平显着相关。在多变量模型中,随机分组时较高的支气管扩张剂反应(β= 0.22; P <.0001),log PC20(β= 1.82; P <.0001)和FEV1(β= 0.58; P <.0001)均与较高的相关性相关。 4年后,支气管扩张剂前FEV1的水平为预期的百分比。支气管扩张剂前强迫肺活量和FEV1 /强迫肺活量比也有相似的关联。在吸入皮质类固醇激素时,基线支气管扩张药反应是肺功能改善的特别有力的预测指标,而对于未随机分配任何控制药物的受试者,气道反应性是更好的预测指标。结论:我们得出结论,基线支气管扩张剂反应,气道反应性和FEV1水平是儿童哮喘继发FEV1水平的独立预测因子,可能对症状持续至成年期具有治疗特异性的预后意义。临床意义:在哮喘中,支气管扩张药和支气管收缩反应是未来肺功能的独立预测因子,不应互换使用。支气管扩张药反应可能表明对吸入皮质类固醇激素反应良好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号